Abbott Laboratories Stock London S.E.
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
09:56:06 2026-09-17 am EDT
|
5-day change | 1st Jan Change | ||
| 101.18 USD | -1.67% |
|
-1.61% | -18.72% |
| Market Cap | 177B 153B 145B 132B 247B 16,992B 248B 1,732B 669B 8,618B 665B 651B 27,471B | P/E 2026 * |
29x | P/E 2027 * | 22.5x |
|---|---|---|---|---|---|
| Enterprise Value | 201B 174B 165B 150B 280B 19,288B 282B 1,966B 760B 9,783B 755B 739B 31,183B | EV / Sales 2026 * |
4x | EV / Sales 2027 * | 3.63x |
| Free-Float |
86.16% | Yield 2026 * |
2.51% | Yield 2027 * | 2.68% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
|
London S.E.
| ABT | Delayed | |
|
Xetra
| ABL | Delayed | |
|
Tradegate
| ABL | Real-time | |
|
Boerse Muenchen
| ABL | Real-time | |
|
Mexican S.E.
| ABT * | End-of-day quote | |
|
CBOE
| ABT | Real-time | |
|
Kazakhstan S.E.
| ABT_KZ | End-of-day quote | |
|
Swiss Exchange
| ABT | Delayed | |
|
Lima
| ABTUS | End-of-day quote | |
|
Wiener Boerse
| ABT | End-of-day quote | |
|
CBOE
| Real-time | ||
|
Santiago S.E.
| ABT | End-of-day quote | |
|
Santiago S.E.
| ABTCL | End-of-day quote | |
|
Deutsche Boerse AG
| ABL | Delayed | |
|
Börse Stuttgart
| ABL | Delayed | |
|
Borsa Italiana
| 1ABT | End-of-day quote |
Last Transcript: Abbott Laboratories
| 1 day | +1.93% | ||
| 1 week | -2.75% | ||
| Current month | -6.95% | ||
| 1 month | -7.62% | ||
| 3 months | +14.82% | ||
| 6 months | -5.85% | ||
| Current year | -18.21% |
| 1 week | 100.4 |  | 105.14 |
| 1 month | 100.4 | | 118 |
| Current year | 82.05 | | 129.37 |
| 1 year | 82.05 | | 137.44 |
| 3 years | 82.05 | | 141.41 |
| 5 years | 82.05 | | 142.15 |
| 10 years | 38.23 | | 142.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 2020-03-30 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 2023-08-31 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 2011-12-08 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 2011-12-08 |
Daniel Starks
BRD | Director/Board Member | 71 | 2017-02-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.87% | -2.75% | - | - | 177B | |
| +0.32% | -2.73% | -22.90% | +0.61% | 177B | |
| -1.23% | +0.77% | -1.69% | +13.24% | 118B | |
| -1.48% | -1.49% | +9.83% | +78.64% | 60.78B | |
| -2.19% | +1.14% | -2.34% | -31.05% | 49.53B | |
| +1.18% | -2.07% | +6.21% | +40.76% | 48.29B | |
| +1.03% | +4.12% | +14.10% | -9.35% | 32.96B | |
| +2.74% | -3.11% | - | - | 28.94B | |
| -0.82% | +7.44% | +40.12% | -8.16% | 25.48B | |
| +0.36% | +4.46% | +9.66% | -20.96% | 21.77B | |
| Average | +0.71% | +0.55% | +6.62% | +7.97% | 62.59B | |
| Weighted average by Cap. | +1.30% | -0.55% | -3.33% | +11.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.2B 43.51B 41.12B 37.33B 69.97B 4,816B 70.39B 491B 190B 2,443B 189B 184B 7,786B | 54.53B 47.25B 44.66B 40.55B 75.99B 5,231B 76.45B 533B 206B 2,653B 205B 200B 8,457B |
| Net income | 6.3B 5.46B 5.16B 4.69B 8.78B 605B 8.84B 61.63B 23.82B 307B 23.68B 23.15B 978B | 7.98B 6.91B 6.53B 5.93B 11.12B 765B 11.18B 78.01B 30.14B 388B 29.97B 29.3B 1,237B |
| Net Debt | 23.94B 20.75B 19.61B 17.8B 33.36B 2,297B 33.56B 234B 90.45B 1,165B 89.93B 87.93B 3,713B | 20.96B 18.16B 17.17B 15.58B 29.21B 2,010B 29.38B 205B 79.18B 1,020B 78.73B 76.98B 3,250B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-17 | $102.26 | -0.62% | 31 |
| 26-09-16 | $103.17 | +0.69% | 2,600 |
| 26-09-15 | $102.46 | -0.43% | 7,966 |
| 26-09-14 | $102.90 | +0.74% | 8,116 |
| 26-09-11 | $102.14 | -1.72% | 25,253 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
